<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>cc7754</ui>
   <ji>CCJ</ji>
   <fm>
      <dochead>Commentary</dochead>
      <bibl>
         <title>
            <p>Sepsis-associated delirium: the pro and con of C5a blockade</p>
         </title>
         <aug>
            <au ca="yes" id="A1">
               <snm>Annane</snm>
               <fnm>Djillali</fnm>
               <insr iid="I1"/>
               <email>djillali.annane@rpc.aphp.fr</email>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>General Intensive Care Unit, Raymond Poincar&#233; Hospital (AP-HP), University of Versailles SQY (UniverSud Paris), 104 boulevard Raymond Poincar&#233;, 92380 Garches, France</p>
            </ins>
         </insg>
         <source>Critical Care</source>
         <issn>1364-8535</issn>
         <pubdate>2009</pubdate>
         <volume>13</volume>
         <issue>2</issue>
         <fpage>135</fpage>
         <url>http://ccforum.com/content/13/2/135</url>
         <note>See related research by Flierl <it>et al.</it>, <url>http://ccforum.com/content/13/1/R12</url></note>
         <xrefbib>
            
         <pubidlist><pubid idtype="pmpid">19439043</pubid><pubid idtype="doi">10.1186/cc7754</pubid></pubidlist></xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>22</day>
               <month>4</month>
               <year>2009</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2009</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
      <abs>
         <sec>
            <st>
               <p>Abstract</p>
            </st>
            <p>The intimate mechanisms of sepsis-induced delirium are unknown. Among the potential contributing factors, the breakdown of the blood&#8211;brain barrier is considered a key determinant of brain dysfunction. The complement activation is paramount to an appropriate activation of the central nervous system during stress. C3a and C5a have been extensively studied and may be involved in sepsis-induced delirium. Here we discuss the pro and con for inhibiting C5a to attenuate brain damage during sepsis. In particular, we discuss the hypothesis that C5a increased blood&#8211;brain barrier permeability amy ease the brain to mount an appropriate response to sepsis. Thus, blockade of C5a may be detrimental, resulting in an attenuated response of the stress system.</p>
         </sec>
      </abs>
   </fm>
   <bdy>
      <sec>
         <st>
            <p/>
         </st>
         <p>Flierl and colleagues showed recently in mice that systemic administration of neutralising anti-C5a antibody prevented caecal ligation and puncture-induced damage to the blood&#8211;brain barrier (BBB) and dysfunction of the pituitary gland <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. These data are in line with the well-established role of the complement anaphylatoxin C5a in brain signalling during inflammation <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>.</p>
         <p>C5 is constitutively expressed in neuronal and non-neuronal brain cells. Following endotoxin administration, the C5a receptor becomes upregulated in a time-dependent manner within the cerebral endothelium, then in microglial cells neighbouring the endothelium and, finally, in deeper brain parenchyma. The complement activation has been demonstrated in numerous inflammatory and degenerative, acute and chronic, diseases of the brain <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>. Following C5a upregulation, microglial cells are recruited and activated to release proinflammatory cytokines, and their phagocytosis capacity is enhanced, and astrocytes are also activated <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>. Subsequently, C5a contributes to the activation of the stress system. Indeed, systemic blockade of C5a reduced lipopolysaccharide-induced neuronal activation in the paraventricular nuclei and amygdala <abbrgrp><abbr bid="B5">5</abbr></abbrgrp>. Similarly, in Flierl and colleagues' study, C5a blockade almost fully blunted the pituitary response to caecal ligation and puncture-induced sepsis <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>.</p>
      </sec>
      <sec>
         <st>
            <p>The pro side for inhibition of C5a</p>
         </st>
         <p>Adequate neuronal function requires a highly regulated extra-cellular environment, wherein the concentrations of ions such as sodium, potassium and calcium must be maintained within very narrow ranges. The brain accounts for approximately 20% of oxygen consumption in humans, and is also extremely sensitive to a wide range of chemicals that are circulating without harm to peripheral organ systems. It is therefore paramount that the interface between the central nervous system and the peripheral circulatory system (that is, the BBB) functions as a dynamic regulator of ion balance, as a facilitator of nutrient transport, and as a barrier to potentially harmful molecules.</p>
         <p>Intuitively, the disruption of this barrier may flood the brain with neurotoxic substances. Subsequently, it is commonly thought that the breakdown of the BBB is a key causative factor of sepsis-associated delirium <abbrgrp><abbr bid="B6">6</abbr><abbr bid="B7">7</abbr><abbr bid="B8">8</abbr></abbrgrp>. The stimulation of cerebrovascular endothelial cells with septic plasma induced dissociation of tight junction proteins such as occludin from the cytoskeletal network, and subsequently increased the size-selective transendothelial solute flux <abbrgrp><abbr bid="B9">9</abbr></abbrgrp>.</p>
         <p>In patients, vasogenic oedema can be demonstrated by magnetic resonance imaging within the Wirchow&#8211;Robin spaces, within the posterior cerebral hemispheres and, less frequently, as diffuse white matter oedema. Various mediators cause BBB hyperpermeability, such as bradykinin, IL-1&#946;, TNF&#945; and complement <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>. Recent experiments suggest that upregulation of C3 induced a breakdown in the BBB and increased gliosis, increased the water content, and upregulated Toll-like receptor 4 with subsequent alterations in TNF, inducible nitric oxide synthase and aquaporin 4 <abbrgrp><abbr bid="B10">10</abbr></abbrgrp>.</p>
         <p>Extending these findings, Flierl and colleagues were able to prevent the damage to the BBB by systemic administration of an anti-C5a neutralising antibody <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. Unfortunately, they did not look at neuronal activation or damage to confirm any neuroprotection. Of note, interfering with complement activation either by blocking C5a or its receptor <abbrgrp><abbr bid="B11">11</abbr></abbrgrp>, or by inhibitor of the alternative complement pathway, attenuates neuronal death in experimental traumatic brain injury <abbrgrp><abbr bid="B12">12</abbr></abbrgrp>.</p>
      </sec>
      <sec>
         <st>
            <p>The con side of blocking C5a</p>
         </st>
         <p>To survive stress, the brain must be alerted, must identify the stressors and must mount an appropriate response. The limbic system, the hypothalamic&#8211;pituitary axis and the locus coeruleus/noradrenergic system are tightly interconnected to orchestrate homeostasis in stress. These structures are all behind the BBB. The circulating inflammatory mediators may reach these brain areas via the circumventricular organs that lack a BBB or by active transport across the BBB <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>.</p>
         <p>It is also possible that specific systems are in place to open the BBB as a normal response to severe infection. Indeed, by increasing the BBB permeability, C5a may ease pathogen-associated molecular pattern access to brain sensing areas such as paraventricular and amygdala cells. Upregulation of C5a therefore allows the stress system to mount an appropriate response. This assumption is supported by at least three major facts. Firstly, blockade of C5a markedly reduced the activation of the hypothalamic&#8211;pituitary cells <abbrgrp><abbr bid="B5">5</abbr></abbrgrp> and decreased the corticotrophin and corticosterone levels <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. This effect correlated with decreased expression of pathogen-associated molecular pattern <abbrgrp><abbr bid="B5">5</abbr></abbrgrp> and of cytokines <abbrgrp><abbr bid="B1">1</abbr><abbr bid="B5">5</abbr></abbrgrp>. The resulting inappropriate hypothalamic&#8211;pituitary adrenal axis is probably detrimental in sepsis <abbrgrp><abbr bid="B13">13</abbr></abbrgrp>. Secondly, in patients with sepsis, magnetic resonance imaging studies showed that increased BBB permeability is an early, common, and transient phenomenon <abbrgrp><abbr bid="B8">8</abbr></abbrgrp>. Patients who did survive to sepsis recovered a normal brain. Thirdly, C5-deficient mice or those pretreated with a C5a receptor antagonist are unable to mount a febrile response to intraperitoneal endotoxin challenge <abbrgrp><abbr bid="B14">14</abbr></abbrgrp>.</p>
         <p>Furthermore, C3 is also broadly upregulated during sepsis, and may act as a gatekeeper &#8211; protecting the brain from any live circulating microorganisms while the BBB is rendered permeable. Neuronal excitation involving the excitatory glutamate receptors may be an important underlying mechanism in sepsis-induced altered neurotransmission <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>. Recent reports suggested that C5a induced neuroprotection against glutamate-mediated apoptosis through inhibition of caspase 3 activity, through the mitogen-activated protein kinase transduction pathway, and through regulation of the glutamate receptor GluTR2 <abbrgrp><abbr bid="B15">15</abbr></abbrgrp>. C5 blockade may therefore inhibit select neuroprotective actions of the complement cascade, and may possibly exacerbate neuro-excitatory mechanisms.</p>
         <p>Future studies should investigate neuron survival in the stress system following C5a antibodies, or C5a receptor antagonists or blockade of the alternative complement pathway in experimental sepsis.</p>
      </sec>
      <sec>
         <st>
            <p>Abbreviations</p>
         </st>
         <p>BBB: blood&#8211;brain barrier; IL: interleukin; TNF: tumour necrosis factor.</p>
      </sec>
      <sec>
         <st>
            <p>Competing interests</p>
         </st>
         <p>The author declares that they have no competing interests.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Inhibition of complement C5a prevents breakdown of the blood&#8211;brain barrier and pituitary dysfunction in experimental sepsis</p>
            </title>
            <aug>
               <au>
                  <snm>Flierl</snm>
                  <fnm>MA</fnm>
               </au>
               <au>
                  <snm>Stahel</snm>
                  <fnm>PF</fnm>
               </au>
               <au>
                  <snm>Rittirsch</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Huber-Lang</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Niederbichler</snm>
                  <fnm>AD</fnm>
               </au>
               <au>
                  <snm>Hoesel</snm>
                  <fnm>LM</fnm>
               </au>
               <au>
                  <snm>Touban</snm>
                  <fnm>BM</fnm>
               </au>
               <au>
                  <snm>Morgan</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Smith</snm>
                  <fnm>WR</fnm>
               </au>
               <au>
                  <snm>Ward</snm>
                  <fnm>PA</fnm>
               </au>
               <au>
                  <snm>Ipaktchi</snm>
                  <fnm>K</fnm>
               </au>
            </aug>
            <source>Crit Care</source>
            <pubdate>2009</pubdate>
            <volume>13</volume>
            <fpage>R12</fpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1186/cc7710</pubid>
                  <pubid idtype="pmpid" link="fulltext">19196477</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>The complement system is an integrated part of the natural innate immune response in the brain</p>
            </title>
            <aug>
               <au>
                  <snm>Nadeau</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Rivest</snm>
                  <fnm>S</fnm>
               </au>
            </aug>
            <source>FASEB J</source>
            <pubdate>2001</pubdate>
            <volume>15</volume>
            <fpage>1410</fpage>
            <lpage>1412</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">11387240</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Expression of complement in the brain: role in health and disease</p>
            </title>
            <aug>
               <au>
                  <snm>Morgan</snm>
                  <fnm>BP</fnm>
               </au>
               <au>
                  <snm>Gasque</snm>
                  <fnm>P</fnm>
               </au>
            </aug>
            <source>Immunol Today</source>
            <pubdate>1996</pubdate>
            <volume>17</volume>
            <fpage>461</fpage>
            <lpage>466</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/0167-5699(96)20028-F</pubid>
                  <pubid idtype="pmpid" link="fulltext">8908810</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B4">
            <title>
               <p>Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system</p>
            </title>
            <aug>
               <au>
                  <snm>Gasque</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Singhrao</snm>
                  <fnm>SK</fnm>
               </au>
               <au>
                  <snm>Neal</snm>
                  <fnm>JW</fnm>
               </au>
               <au>
                  <snm>G&#246;tze</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Morgan</snm>
                  <fnm>PB</fnm>
               </au>
            </aug>
            <source>Am J Pathol</source>
            <pubdate>1997</pubdate>
            <volume>150</volume>
            <fpage>31</fpage>
            <lpage>41</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">1858516</pubid>
                  <pubid idtype="pmpid">9006319</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B5">
            <title>
               <p>Systemic blockade of complement C5a receptors reduces lipopolysacharride-induced responses in the paraventricular nucleus and the central amygdala</p>
            </title>
            <aug>
               <au>
                  <snm>Crane</snm>
                  <fnm>JW</fnm>
               </au>
               <au>
                  <snm>Buller</snm>
                  <fnm>KM</fnm>
               </au>
            </aug>
            <source>Neurosci Lett</source>
            <pubdate>2007</pubdate>
            <volume>424</volume>
            <fpage>10</fpage>
            <lpage>15</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.neulet.2007.07.012</pubid>
                  <pubid idtype="pmpid" link="fulltext">17703884</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B6">
            <title>
               <p>Sepsis associated delirium</p>
            </title>
            <aug>
               <au>
                  <snm>Ebersoldt</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Sharshar</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Annane</snm>
                  <fnm>D</fnm>
               </au>
            </aug>
            <source>Intensive Care Med</source>
            <pubdate>2007</pubdate>
            <volume>33</volume>
            <fpage>941</fpage>
            <lpage>950</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1007/s00134-007-0622-2</pubid>
                  <pubid idtype="pmpid" link="fulltext">17410344</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B7">
            <title>
               <p>Faecal peritonitis causes oedema and neuronal injury in pig cerebral cortex</p>
            </title>
            <aug>
               <au>
                  <snm>Papadopoulos</snm>
                  <fnm>MC</fnm>
               </au>
               <au>
                  <snm>Lamb</snm>
                  <fnm>FJ</fnm>
               </au>
               <au>
                  <snm>Moss</snm>
                  <fnm>RF</fnm>
               </au>
               <au>
                  <snm>Davies</snm>
                  <fnm>DC</fnm>
               </au>
               <au>
                  <snm>Tighe</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Bennett</snm>
                  <fnm>ED</fnm>
               </au>
            </aug>
            <source>Clin Sci (Lond)</source>
            <pubdate>1999</pubdate>
            <volume>96</volume>
            <fpage>461</fpage>
            <lpage>466</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">10209077</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B8">
            <title>
               <p>Brain lesions in septic shock: a magnetic resonance imaging study</p>
            </title>
            <aug>
               <au>
                  <snm>Sharshar</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Carlier</snm>
                  <fnm>R</fnm>
               </au>
               <au>
                  <snm>Bernard</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Guidoux</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Brouland</snm>
                  <fnm>JP</fnm>
               </au>
               <au>
                  <snm>Nardi</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>de la Grandmaison</snm>
                  <fnm>GL</fnm>
               </au>
               <au>
                  <snm>Aboab</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Gray</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Menon</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Annane</snm>
                  <fnm>D</fnm>
               </au>
            </aug>
            <source>Intensive Care Med</source>
            <pubdate>2007</pubdate>
            <volume>33</volume>
            <fpage>798</fpage>
            <lpage>806</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1007/s00134-007-0598-y</pubid>
                  <pubid idtype="pmpid" link="fulltext">17377766</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B9">
            <title>
               <p>Role of eNOS-derived nitric oxide (NO) in activation and dysfunction of cerebrovascular endothelial cells during early onsets of sepsis</p>
            </title>
            <aug>
               <au>
                  <snm>Handa</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Stephen</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Cepinskas</snm>
                  <fnm>G</fnm>
               </au>
            </aug>
            <source>Am J Physiol Heart Circ Physiol</source>
            <pubdate>2008</pubdate>
            <volume>295</volume>
            <fpage>H1712</fpage>
            <lpage>H1719</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1152/ajpheart.00476.2008</pubid>
                  <pubid idtype="pmpid" link="fulltext">18723768</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B10">
            <title>
               <p>The role of the complement cascade in endotoxin-induced septic encephalopathy</p>
            </title>
            <aug>
               <au>
                  <snm>Jacob</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Hensley</snm>
                  <fnm>LK</fnm>
               </au>
               <au>
                  <snm>Safratowich</snm>
                  <fnm>BD</fnm>
               </au>
               <au>
                  <snm>Quigg</snm>
                  <fnm>RJ</fnm>
               </au>
               <au>
                  <snm>Alexander</snm>
                  <fnm>JJ</fnm>
               </au>
            </aug>
            <source>Lab Invest</source>
            <pubdate>2007</pubdate>
            <volume>87</volume>
            <fpage>1186</fpage>
            <lpage>1194</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/labinvest.3700686</pubid>
                  <pubid idtype="pmpid" link="fulltext">17922019</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B11">
            <title>
               <p>Complement C3 and C5 play critical roles in traumatic brain cryoinjury: blocking effects on neutrophils extravasation by C5a receptor antagonist</p>
            </title>
            <aug>
               <au>
                  <snm>Sewell</snm>
                  <fnm>DL</fnm>
               </au>
               <au>
                  <snm>Nacewicz</snm>
                  <fnm>B</fnm>
               </au>
               <au>
                  <snm>Liu</snm>
                  <fnm>F</fnm>
               </au>
               <au>
                  <snm>Macvilay</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Erdei</snm>
                  <fnm>A</fnm>
               </au>
               <au>
                  <snm>Lambris</snm>
                  <fnm>JD</fnm>
               </au>
               <au>
                  <snm>Sandor</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Fabry</snm>
                  <fnm>Z</fnm>
               </au>
            </aug>
            <source>J Neuroimmunol</source>
            <pubdate>2004</pubdate>
            <volume>155</volume>
            <fpage>55</fpage>
            <lpage>63</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.jneuroim.2004.06.003</pubid>
                  <pubid idtype="pmpid" link="fulltext">15342196</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B12">
            <title>
               <p>Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice</p>
            </title>
            <aug>
               <au>
                  <snm>Leinhase</snm>
                  <fnm>I</fnm>
               </au>
               <au>
                  <snm>Rozanski</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Harhausen</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Thurman</snm>
                  <fnm>JM</fnm>
               </au>
               <au>
                  <snm>Schmidt</snm>
                  <fnm>OI</fnm>
               </au>
               <au>
                  <snm>Hossini</snm>
                  <fnm>AM</fnm>
               </au>
               <au>
                  <snm>Taha</snm>
                  <fnm>ME</fnm>
               </au>
               <au>
                  <snm>Rittirsch</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Ward</snm>
                  <fnm>PA</fnm>
               </au>
               <au>
                  <snm>Holers</snm>
                  <fnm>VM</fnm>
               </au>
               <au>
                  <snm>Ertel</snm>
                  <fnm>W</fnm>
               </au>
               <au>
                  <snm>Stahel</snm>
                  <fnm>PF</fnm>
               </au>
            </aug>
            <source>J Neuroinflammation</source>
            <pubdate>2007</pubdate>
            <volume>4</volume>
            <fpage>13</fpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmpid" link="fulltext">17474994</pubid>
                  <pubid idtype="doi">10.1186/1742-2094-4-13</pubid>
                  <pubid idtype="pmcid">1867808</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B13">
            <title>
               <p>Adrenal insufficiency in septic shock</p>
            </title>
            <aug>
               <au>
                  <snm>Maxime</snm>
                  <fnm>V</fnm>
               </au>
               <au>
                  <snm>Lesur</snm>
                  <fnm>O</fnm>
               </au>
               <au>
                  <snm>Annane</snm>
                  <fnm>D</fnm>
               </au>
            </aug>
            <source>Clin Chest Med</source>
            <pubdate>2009</pubdate>
            <volume>30</volume>
            <fpage>17</fpage>
            <lpage>27</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.ccm.2008.10.003</pubid>
                  <pubid idtype="pmpid" link="fulltext">19186278</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B14">
            <title>
               <p>Complement component c5a is integral to the febrile response of mice to lipopolysaccharide</p>
            </title>
            <aug>
               <au>
                  <snm>Li</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Boackle</snm>
                  <fnm>SA</fnm>
               </au>
               <au>
                  <snm>Holers</snm>
                  <fnm>VM</fnm>
               </au>
               <au>
                  <snm>Lambris</snm>
                  <fnm>JD</fnm>
               </au>
               <au>
                  <snm>Blatteis</snm>
                  <fnm>CM</fnm>
               </au>
            </aug>
            <source>Neuroimmunomodulation</source>
            <pubdate>2005</pubdate>
            <volume>12</volume>
            <fpage>67</fpage>
            <lpage>80</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1159/000083578</pubid>
                  <pubid idtype="pmpid" link="fulltext">15785108</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B15">
            <title>
               <p>Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo</p>
            </title>
            <aug>
               <au>
                  <snm>Mukherjee</snm>
                  <fnm>P</fnm>
               </au>
               <au>
                  <snm>Thomas</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Pasinetti</snm>
                  <fnm>GM</fnm>
               </au>
            </aug>
            <source>J Neuroinflammation</source>
            <pubdate>2008</pubdate>
            <volume>5</volume>
            <fpage>5</fpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmpid" link="fulltext">18230183</pubid>
                  <pubid idtype="doi">10.1186/1742-2094-5-5</pubid>
                  <pubid idtype="pmcid">2246107</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>
